HQH (abrdn Healthcare Investors) Tariff Resilience Score: 8/10 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HQH abrdn Healthcare Investors HQH
48 GF Score
Price $21.04
GF Value $50.26
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is abrdn Healthcare Investors Tariff Resilience Score?

abrdn Healthcare Investors HQH -0.38% 48 Tariff Resilience Score is 8 as of Jul. 15, 2026. GuruFocus rates HQH with a GF Score™ of 48/100 and a GF Value™ of $50.26 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,692 Asset Management companies, abrdn Healthcare Investors ranks better than 90.48% on this metric.

abrdn Healthcare Investors has the Tariff Resilience Score of 8, which implies that the company might have Highly Resilient.

abrdn Healthcare Investors has As an investment trust focused on healthcare, HQH has limited direct exposure to tariffs. Its investments are primarily in domestic healthcare companies, which are less affected by international trade policies.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes abrdn Healthcare Investors might have Highly Resilient.

abrdn Healthcare Investors  (NYSE:HQH) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

abrdn Healthcare Investors Tariff Resilience Score Related Terms

HQH vs DSL, NMZ, JFR: Tariff Resilience Score Comparison

For the Asset Management subindustry, abrdn Healthcare Investors's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

abrdn Healthcare Investors Tariff Resilience Score vs Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Healthcare Investors's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where abrdn Healthcare Investors's Tariff Resilience Score falls into.


HQH
48GF Score
abrdn Healthcare Investors HQH
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 8 mean?
abrdn Healthcare Investors (HQH) has a Tariff Resilience Score of 8 as of Jul. 15, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, abrdn Healthcare Investors ranks #161 out of 1692 companies in the Asset Management industry, placing it in the top 9.5%.
Is abrdn Healthcare Investors' Tariff Resilience Score too high?
abrdn Healthcare Investors' current Tariff Resilience Score is 8. Based on the distribution chart, abrdn Healthcare Investors ranks #161 out of 1692 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, abrdn Healthcare Investors has a GF Score™ of 48/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does abrdn Healthcare Investors' Tariff Resilience Score compare to DSL and NMZ?
According to the Asset Management industry distribution chart, abrdn Healthcare Investors ranks #161 out of 1692 companies for Tariff Resilience Score. This places abrdn Healthcare Investors in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for an Asset Management company?
A good Tariff Resilience Score depends on the Asset Management industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. abrdn Healthcare Investors's current Tariff Resilience Score is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is abrdn Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, abrdn Healthcare Investors (HQH) is currently considered Possible Value Trap. The stock's GF Value™ is $50.26, compared to a current price of $21.04 — trading 58.1% below its estimated fair value. The current Tariff Resilience Score is 8. abrdn Healthcare Investors' overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For abrdn Healthcare Investors (HQH), the current Tariff Resilience Score is 8 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is abrdn Healthcare Investors (HQH) Overvalued in 2026?

Based on GuruFocus' analysis, abrdn Healthcare Investors stock appears to be undervalued. The current stock price of $21.04 is trading 58.1% below its estimated GF Value™ of $50.26. GuruFocus considers abrdn Healthcare Investors to be Possible Value Trap.

Key valuation signals for HQH:

  • Tariff Resilience Score: 8
  • GF Value™: $50.26 vs. price of $21.04 (58.1% below fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the HQH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

abrdn Healthcare Investors Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
48GF Score

Get the complete analysis for HQH

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.04
Price
$50.26
GF Value